(MedPage Today) — In a new clinical guideline, the American College of Physicians recommends adding an SGLT2 inhibitor or GLP-1 receptor agonist to metformin and lifestyle modifications for adults with inadequately controlled type 2 diabetes…
Source link : https://www.medpagetoday.com/endocrinology/generalendocrinology/115679
Author :
Publish date : 2025-05-20 18:51:00
Copyright for syndicated content belongs to the linked Source.
